PMID: 15230489Jul 3, 2004Paper

The metabolic syndrome: an emerging risk state for cardiovascular disease

Vascular Medicine
Dorairaj Prabhakaran, Sonia S Anand

Abstract

The common clustering of glucose intolerance, insulin resistance, abdominal adiposity, elevated blood pressure, and low HDL cholesterol is referred to as metabolic syndrome. Individuals with this syndrome have an increased risk of developing cardiovascular disease (CVD). The World Health Organisation and the National Cholesterol Education Programme's Adult Treatment Panel III (NCEP-ATP III) have outlined specific diagnostic criteria for the diagnosis of the metabolic syndrome to help in the identification of this syndrome in clinical practice. While the WHO criteria were specifically developed for use in research, the NCEP criteria are useful in clinical diagnosis of the metabolic syndrome. The metabolic syndrome is amenable to lifestyle modifications such as increased physical activity, weight loss, and possibly intake of low-glycemic foods. Drug therapy may be used to treat individual components of the syndrome such as elevated blood pressure and dyslipidemia. To control elevated glucose levels (when there is failure of lifestyle modification), medications such as metformin, thiazolidinedione derivatives and alpha glucosidase inhibitors may be used.

References

Dec 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·K R FeingoldR M Krauss
Jul 1, 1992·Diabetes·B C MartinA S Krolewski
Oct 26, 1991·BMJ : British Medical Journal·C N HalesP D Winter
Apr 1, 1991·American Heart Journal·W B KannelT J Zhang
Nov 17, 1988·The New England Journal of Medicine·S M HaffnerJ K Patterson
Jan 2, 1988·British Medical Journal·G G GilesP Foley
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J R PatschA M Gotto
Oct 4, 1995·JAMA : the Journal of the American Medical Association·C J BousheyA G Motulsky
Jul 15, 1995·BMJ : British Medical Journal·D J Barker
Aug 12, 1995·BMJ : British Medical Journal·M Green
Dec 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·K L EdwardsJ V Selby
Jan 1, 1994·BMJ : British Medical Journal·M MarberD Yellon
Mar 1, 1993·Diabetologia·K PhippsP M Clark
Jan 20, 1996·BMJ : British Medical Journal·T E ForresterP Scott
Apr 6, 1996·Lancet·H C Gerstein, S Yusuf

❮ Previous
Next ❯

Citations

May 28, 2005·Current Rheumatology Reports·Naohiko AnzaiHitoshi Endou
Apr 25, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Margaret E E JonesEvan R Simpson
Jun 22, 2011·Clinical Pharmacology and Therapeutics·D Prabhakaran, K S Reddy
Oct 12, 2012·International Journal of Occupational Medicine and Environmental Health·Iraj MohebbiMirhosein Seyedmohammadzad
Oct 11, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Kirsten A ArmstrongNicole M Isbel
Nov 26, 2008·Metabolic Syndrome and Related Disorders·Tahna L PettmanPeter R C Howe
Jul 10, 2007·Vascular Medicine·Markus ReiterRobert A Bucek
May 4, 2010·The Journal of Clinical Hypertension·Tomoyuki KawadaMasao Katsumata
Aug 20, 2005·Nephrology·Kirsten A ArmstrongNicole M Isbel
May 19, 2011·Biological Research for Nursing·Queen Henry-OkaforMichelle S C Khoo
Feb 7, 2007·Current Opinion in Rheumatology·Naohiko AnzaiHitoshi Endou
Sep 18, 2016·The Kaohsiung Journal of Medical Sciences·Wen-Li WangYih-Jin Hu
Jul 1, 2015·Canadian Journal of Public Health = Revue Canadienne De Santé Publique·Dessalegn Y MelesseRobert B Tate
Mar 29, 2020·Tissue Engineering. Part B, Reviews·Michelle McCarthyTrivia Frazier
Aug 31, 2006·American Journal of Physiology. Endocrinology and Metabolism·Anita M van den HoekHanno Pijl
Apr 18, 2015·Indian Journal of Clinical Biochemistry : IJCB·Sajimon ThomasT Vijayakumar
Feb 17, 2006·Trends in Endocrinology and Metabolism : TEM·Margaret E E JonesEvan R Simpson
Jul 24, 2007·The Journal of Steroid Biochemistry and Molecular Biology·M E E JonesE R Simpson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.